Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
46
CBT Quote, Financials, Valuation and Earnings
Last price:
$76.66
Seasonality move
:
1.39%
Day range:
$75.49 - $77.69
52-week range:
$58.33 - $89.15
Dividend yield:
2.34%
P/E ratio:
13.33x
P/S ratio:
1.13x
P/B ratio:
2.52x
Volume:
492.5K
Avg. volume:
504.5K
1-year change:
-11.71%
Market cap:
$4B
Revenue:
$3.7B
EPS (TTM):
$5.70
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4B | $4.3B | $3.9B | $4B | $3.7B | |
| Revenue Growth (YoY) | 30.41% | 26.75% | -9.03% | 1.6% | -7.04% | |
| Cost of Revenues | $2.6B | $3.4B | $3.1B | $3B | $2.8B | |
| Gross Profit | $806M | $885M | $839M | $972M | $946M | |
| Gross Profit Margin | 23.64% | 20.48% | 21.34% | 24.34% | 25.48% | |
| R&D Expenses | $55M | $55M | $57M | $63M | $57M | |
| Selling, General & Admin | $289M | $258M | $253M | $283M | $260M | |
| Other Inc / (Exp) | -$7M | -$192M | -$19M | -$36M | -- | |
| Operating Expenses | $316M | $313M | $310M | $345M | $314M | |
| Operating Income | $490M | $572M | $529M | $627M | $632M | |
| Net Interest Expenses | $52M | $60M | $94M | $84M | $79M | |
| EBT. Incl. Unusual Items | $406M | $335M | $451M | $529M | $565M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $123M | $102M | -$28M | $111M | $196M | |
| Net Income to Company | $286M | $243M | $484M | $424M | $376M | |
| Minority Interest in Earnings | $36M | $34M | $39M | $44M | $45M | |
| Net Income to Common Excl Extra Items | $283M | $240M | $476M | $418M | $372M | |
| Basic EPS (Cont. Ops) | $4.36 | $3.65 | $7.79 | $6.79 | $6.07 | |
| Diluted EPS (Cont. Ops) | $4.35 | $3.62 | $7.73 | $6.71 | $6.01 | |
| Weighted Average Basic Share | $56.7M | $56.5M | $56.1M | $55.1M | $53.7M | |
| Weighted Average Diluted Share | $56.8M | $56.9M | $56.5M | $55.7M | $54.2M | |
| EBITDA | $650M | $718M | $673M | $778M | $786M | |
| EBIT | $490M | $572M | $529M | $627M | $632M | |
| Revenue (Reported) | $3.4B | $4.3B | $3.9B | $4B | $3.7B | |
| Operating Income (Reported) | $490M | $572M | $529M | $627M | $632M | |
| Operating Income (Adjusted) | $490M | $572M | $529M | $627M | $632M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $968M | $965M | $958M | $955M | $849M | |
| Revenue Growth (YoY) | 29.76% | -0.31% | -0.73% | -0.31% | -11.1% | |
| Cost of Revenues | $769M | $784M | $740M | $720M | $632M | |
| Gross Profit | $199M | $181M | $218M | $235M | $217M | |
| Gross Profit Margin | 20.56% | 18.76% | 22.76% | 24.61% | 25.56% | |
| R&D Expenses | $13M | $13M | $15M | $14M | $13M | |
| Selling, General & Admin | $71M | $60M | $67M | $66M | $69M | |
| Other Inc / (Exp) | -$198M | -$8M | -$29M | $1M | -- | |
| Operating Expenses | $83M | $73M | $82M | $80M | $81M | |
| Operating Income | $116M | $108M | $136M | $155M | $136M | |
| Net Interest Expenses | $13M | $23M | $23M | $19M | $19M | |
| EBT. Incl. Unusual Items | -$93M | $84M | $94M | $144M | $118M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$12M | $20M | $34M | $41M | $37M | |
| Net Income to Company | -$80M | $66M | $61M | $104M | $81M | |
| Minority Interest in Earnings | $9M | $12M | $11M | $11M | $9M | |
| Net Income to Common Excl Extra Items | -$80M | $65M | $61M | $103M | $81M | |
| Basic EPS (Cont. Ops) | -$1.57 | $0.94 | $0.90 | $1.69 | $1.37 | |
| Diluted EPS (Cont. Ops) | -$1.57 | $0.93 | $0.90 | $1.67 | $1.36 | |
| Weighted Average Basic Share | $56.8M | $56.3M | $55.3M | $54.3M | $52.7M | |
| Weighted Average Diluted Share | $56.8M | $56.7M | $55.8M | $55M | $52.9M | |
| EBITDA | $155M | $143M | $177M | $192M | $177M | |
| EBIT | $116M | $108M | $136M | $155M | $136M | |
| Revenue (Reported) | $968M | $965M | $958M | $955M | $849M | |
| Operating Income (Reported) | $116M | $108M | $136M | $155M | $136M | |
| Operating Income (Adjusted) | $116M | $108M | $136M | $155M | $136M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.6B | $4.3B | $3.9B | $4B | $3.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.8B | $3.5B | $3B | $3B | $2.7B | |
| Gross Profit | $809M | $868M | $876M | $978M | $922M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $54M | $55M | $59M | $62M | $58M | |
| Selling, General & Admin | $299M | $247M | $260M | $282M | $263M | |
| Other Inc / (Exp) | -$196M | -$2M | -$40M | -$6M | -- | |
| Operating Expenses | $329M | $302M | $319M | $344M | $320M | |
| Operating Income | $480M | $566M | $557M | $634M | $602M | |
| Net Interest Expenses | $52M | $71M | $95M | $82M | $80M | |
| EBT. Incl. Unusual Items | $214M | $512M | $461M | $579M | $539M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $82M | $134M | -$14M | $118M | $192M | |
| Net Income to Company | $136M | $389M | $479M | $467M | $353M | |
| Minority Interest in Earnings | $35M | $37M | $38M | $44M | $43M | |
| Net Income to Common Excl Extra Items | $134M | $386M | $472M | $462M | $350M | |
| Basic EPS (Cont. Ops) | $1.75 | $6.19 | $7.81 | $7.62 | $5.73 | |
| Diluted EPS (Cont. Ops) | $1.74 | $6.14 | $7.71 | $7.54 | $5.70 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $640M | $708M | $707M | $781M | $760M | |
| EBIT | $480M | $566M | $557M | $634M | $602M | |
| Revenue (Reported) | $3.6B | $4.3B | $3.9B | $4B | $3.6B | |
| Operating Income (Reported) | $480M | $566M | $557M | $634M | $602M | |
| Operating Income (Adjusted) | $480M | $566M | $557M | $634M | $602M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $968M | $965M | $958M | $955M | $849M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $769M | $784M | $740M | $720M | $632M | |
| Gross Profit | $199M | $181M | $218M | $235M | $217M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $13M | $13M | $15M | $14M | $13M | |
| Selling, General & Admin | $71M | $60M | $67M | $66M | $69M | |
| Other Inc / (Exp) | -$198M | -$8M | -$29M | $1M | -- | |
| Operating Expenses | $83M | $73M | $82M | $80M | $81M | |
| Operating Income | $116M | $108M | $136M | $155M | $136M | |
| Net Interest Expenses | $13M | $23M | $23M | $19M | $19M | |
| EBT. Incl. Unusual Items | -$93M | $84M | $94M | $144M | $118M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$12M | $20M | $34M | $41M | $37M | |
| Net Income to Company | -$80M | $66M | $61M | $104M | $81M | |
| Minority Interest in Earnings | $9M | $12M | $11M | $11M | $9M | |
| Net Income to Common Excl Extra Items | -$80M | $65M | $61M | $103M | $81M | |
| Basic EPS (Cont. Ops) | -$1.57 | $0.94 | $0.90 | $1.69 | $1.37 | |
| Diluted EPS (Cont. Ops) | -$1.57 | $0.93 | $0.90 | $1.67 | $1.36 | |
| Weighted Average Basic Share | $56.8M | $56.3M | $55.3M | $54.3M | $52.7M | |
| Weighted Average Diluted Share | $56.8M | $56.7M | $55.8M | $55M | $52.9M | |
| EBITDA | $155M | $143M | $177M | $192M | $177M | |
| EBIT | $116M | $108M | $136M | $155M | $136M | |
| Revenue (Reported) | $968M | $965M | $958M | $955M | $849M | |
| Operating Income (Reported) | $116M | $108M | $136M | $155M | $136M | |
| Operating Income (Adjusted) | $116M | $108M | $136M | $155M | $136M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $170M | $206M | $238M | $223M | $258M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $645M | $836M | $695M | $733M | $671M | |
| Inventory | $523M | $664M | $585M | $552M | $504M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $89M | $114M | $108M | $97M | -- | |
| Total Current Assets | $1.4B | $1.8B | $1.6B | $1.6B | $1.5B | |
| Property Plant And Equipment | $1.5B | $1.4B | $1.5B | $1.6B | $1.8B | |
| Long-Term Investments | $50M | $28M | $28M | $31M | $25M | |
| Goodwill | $140M | $129M | $134M | $133M | -- | |
| Other Intangibles | $100M | $63M | $60M | $53M | -- | |
| Other Long-Term Assets | $172M | $178M | $172M | $172M | -- | |
| Total Assets | $3.3B | $3.5B | $3.6B | $3.7B | $3.8B | |
| Accounts Payable | $480M | $533M | $438M | $495M | $459M | |
| Accrued Expenses | $112M | $108M | $107M | $107M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $8M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.1B | $1.1B | $822M | $772M | $957M | |
| Long-Term Debt | $801M | $1.2B | $1.2B | $1.2B | $941M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.2B | $2.5B | $2.2B | $2.1B | $2.1B | |
| Common Stock | $57M | $56M | $55M | $54M | $53M | |
| Other Common Equity Adj | -$289M | -$439M | -$362M | -$360M | -- | |
| Common Equity | $947M | $898M | $1.3B | $1.4B | $1.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $143M | $134M | $143M | $165M | $155M | |
| Total Equity | $1.1B | $1B | $1.4B | $1.6B | $1.7B | |
| Total Liabilities and Equity | $3.3B | $3.5B | $3.6B | $3.7B | $3.8B | |
| Cash and Short Terms | $170M | $206M | $238M | $223M | $258M | |
| Total Debt | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $180M | $190M | $244M | $183M | $230M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $660M | $779M | $726M | $677M | $616M | |
| Inventory | $546M | $704M | $617M | $536M | $503M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $113M | $127M | $105M | $100M | -- | |
| Total Current Assets | $1.6B | $1.8B | $1.7B | $1.5B | $1.5B | |
| Property Plant And Equipment | $1.3B | $1.3B | $1.4B | $1.6B | $1.7B | |
| Long-Term Investments | $24M | $30M | $30M | $21M | $26M | |
| Goodwill | $140M | $133M | $138M | $127M | -- | |
| Other Intangibles | $70M | $63M | $61M | $57M | -- | |
| Other Long-Term Assets | $158M | $170M | $173M | $182M | -- | |
| Total Assets | $3.3B | $3.5B | $3.7B | $3.6B | $3.8B | |
| Accounts Payable | $620M | $630M | $585M | $599M | $575M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $373M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $71M | -- | -- | -- | -- | |
| Total Current Liabilities | $1.3B | $984M | $830M | $747M | $874M | |
| Long-Term Debt | $714M | $1.1B | $1.1B | $1.1B | $854M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.4B | $2.4B | $2.2B | $2.1B | $2B | |
| Common Stock | $57M | $57M | $55M | $54M | $52M | |
| Other Common Equity Adj | -$319M | -$358M | -- | -$457M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $154M | $150M | $146M | $149M | $154M | |
| Total Equity | $948M | $1.2B | $1.5B | $1.5B | $1.7B | |
| Total Liabilities and Equity | $3.3B | $3.5B | $3.7B | $3.6B | $3.8B | |
| Cash and Short Terms | $180M | $190M | $244M | $183M | $230M | |
| Total Debt | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $286M | $243M | $484M | $424M | $376M | |
| Depreciation & Amoritzation | $160M | $146M | $144M | $151M | $154M | |
| Stock-Based Compensation | $21M | $23M | $20M | $25M | $24M | |
| Change in Accounts Receivable | -$215M | -$287M | $153M | -$26M | $76M | |
| Change in Inventories | -$174M | -$259M | $96M | $41M | $47M | |
| Cash From Operations | $257M | $100M | $595M | $692M | $665M | |
| Capital Expenditures | $195M | $211M | $244M | $241M | $274M | |
| Cash Acquisitions | -- | $9M | -- | -- | $27M | |
| Cash From Investing | -$186M | -$118M | -$214M | -$235M | -$298M | |
| Dividends Paid (Ex Special Dividend) | $80M | $84M | $88M | $93M | $96M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $258M | $670M | $108M | $15M | -- | |
| Long-Term Debt Repaid | -$222M | -$372M | -$287M | -$158M | -- | |
| Repurchase of Common Stock | $3M | $53M | $98M | $172M | $168M | |
| Other Financing Activities | -$19M | -$22M | -$42M | -$27M | -- | |
| Cash From Financing | -$60M | $145M | -$403M | -$415M | -$336M | |
| Beginning Cash (CF) | $170M | $206M | $238M | $223M | $258M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19M | $36M | $32M | -$15M | $35M | |
| Ending Cash (CF) | $197M | $151M | $324M | $151M | $297M | |
| Levered Free Cash Flow | $62M | -$111M | $351M | $451M | $391M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$80M | $66M | $61M | $104M | $81M | |
| Depreciation & Amoritzation | $39M | $35M | $41M | $37M | $41M | |
| Stock-Based Compensation | $6M | $6M | $6M | $8M | $3M | |
| Change in Accounts Receivable | -$57M | $80M | -$7M | $18M | $64M | |
| Change in Inventories | -$95M | -$14M | -$19M | -$8M | $2M | |
| Cash From Operations | -$49M | $52M | $105M | $124M | $126M | |
| Capital Expenditures | $30M | $35M | $54M | $104M | $69M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$29M | -$17M | -$54M | -$104M | -$69M | |
| Dividends Paid (Ex Special Dividend) | $21M | $21M | $22M | $24M | $24M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $156M | $11M | -- | $6M | -- | |
| Long-Term Debt Repaid | -$5M | -$54M | -$1M | -$1M | -- | |
| Repurchase of Common Stock | $19M | $17M | $33M | $42M | $52M | |
| Other Financing Activities | -$8M | -$14M | -$12M | -$20M | -- | |
| Cash From Financing | $103M | -$92M | -$29M | -$24M | -$92M | |
| Beginning Cash (CF) | $180M | $190M | $244M | $183M | $230M | |
| Foreign Exchange Rate Adjustment | -$15M | $41M | -$16M | -$36M | $7M | |
| Additions / Reductions | $10M | -$16M | $6M | -$40M | -$28M | |
| Ending Cash (CF) | $175M | $215M | $234M | $107M | $209M | |
| Levered Free Cash Flow | -$79M | $17M | $51M | $20M | $57M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $136M | $389M | $479M | $467M | $353M | |
| Depreciation & Amoritzation | $160M | $142M | $150M | $147M | $158M | |
| Stock-Based Compensation | $23M | $23M | $20M | $27M | $19M | |
| Change in Accounts Receivable | -$196M | -$150M | $66M | -$1M | $122M | |
| Change in Inventories | -$232M | -$178M | $91M | $52M | $57M | |
| Cash From Operations | $187M | $201M | $648M | $711M | $667M | |
| Capital Expenditures | $196M | $216M | $263M | $291M | $239M | |
| Cash Acquisitions | -- | $9M | -- | -- | $27M | |
| Cash From Investing | -$186M | -$106M | -$251M | -$285M | -$263M | |
| Dividends Paid (Ex Special Dividend) | $81M | $84M | $89M | $95M | $96M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $364M | $525M | $97M | $21M | -- | |
| Long-Term Debt Repaid | -$161M | -$421M | -$234M | -$158M | -- | |
| Repurchase of Common Stock | $20M | $51M | $114M | $181M | $178M | |
| Other Financing Activities | -$26M | -$28M | -$40M | -$35M | -- | |
| Cash From Financing | $81M | -$50M | -$340M | -$410M | -$404M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $33M | $10M | $54M | -$61M | $47M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$9M | -$15M | $385M | $420M | $428M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$80M | $66M | $61M | $104M | $81M | |
| Depreciation & Amoritzation | $39M | $35M | $41M | $37M | $41M | |
| Stock-Based Compensation | $6M | $6M | $6M | $8M | $3M | |
| Change in Accounts Receivable | -$57M | $80M | -$7M | $18M | $64M | |
| Change in Inventories | -$95M | -$14M | -$19M | -$8M | $2M | |
| Cash From Operations | -$49M | $52M | $105M | $124M | $126M | |
| Capital Expenditures | $30M | $35M | $54M | $104M | $69M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$29M | -$17M | -$54M | -$104M | -$69M | |
| Dividends Paid (Ex Special Dividend) | $21M | $21M | $22M | $24M | $24M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $156M | $11M | -- | $6M | -- | |
| Long-Term Debt Repaid | -$5M | -$54M | -$1M | -$1M | -- | |
| Repurchase of Common Stock | $19M | $17M | $33M | $42M | $52M | |
| Other Financing Activities | -$8M | -$14M | -$12M | -$20M | -- | |
| Cash From Financing | $103M | -$92M | -$29M | -$24M | -$92M | |
| Beginning Cash (CF) | $180M | $190M | $244M | $183M | $230M | |
| Foreign Exchange Rate Adjustment | -$15M | $41M | -$16M | -$36M | $7M | |
| Additions / Reductions | $10M | -$16M | $6M | -$40M | -$28M | |
| Ending Cash (CF) | $175M | $215M | $234M | $107M | $209M | |
| Levered Free Cash Flow | -$79M | $17M | $51M | $20M | $57M | |
Get CBT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CBT
Sector
P/E ratio
13.33x
20.19x
PEG ratio
0.21x
-0.02x
P/B ratio
2.52x
1.91x
Price / LTM sales
1.13x
1.73x
Growth Metrics
CBT
Sector
Revenue growth
-11.1%
2.37%
Earnings growth
-18.63%
--
Revenue (5-year growth)
7.27%
3.24%
Earnings forecast
$1.38
$0.03
Profitability
CBT
Sector
Profitability FY 2025
$946M
--
Return on invested capital
12.27%
-9.18%
Return on assets
9.29%
-10.59%
Return on equity
21.28%
-9.79%
Earnings Date
Last Earnings Date
Feb
3
Next Earnings Date
May
4
Estimated Next Earnings Date
May
5
Balance Sheet
CBT
Sector
Total cash
$230M
$2.6M
Short term investments
--
$217K
Total assets
$3.8B
$16.7M
Long term debt
$1.1B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 10.82% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.42% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.75% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
